These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29206999)

  • 1. Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    Raizes E; Hader S; Birx D
    J Infect Dis; 2017 Dec; 216(suppl_9):S805-S807. PubMed ID: 29206999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    Minior T; Douglas M; Edgil D; Srivastava M; Crowley J; Firth J; Lapidos-Salaiz I; Williams J; Lee L
    J Infect Dis; 2017 Dec; 216(suppl_9):S812-S815. PubMed ID: 29029317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    Chun HM; Obeng-Aduasare YF; Broyles LN; Ellenberger D
    J Infect Dis; 2017 Dec; 216(suppl_9):S808-S811. PubMed ID: 29029178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022.
    Chun HM; Dirlikov E; Cox MH; Sherlock MW; Obeng-Aduasare Y; Sato K; Voetsch AC; Ater AD; Romano ER; Tomlinson H; Modi S; Achrekar A; Nkengasong J;
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(12):317-324. PubMed ID: 36952290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.
    Lecher SL; Fonjungo P; Ellenberger D; Toure CA; Alemnji G; Bowen N; Basiye F; Beukes A; Carmona S; de Klerk M; Diallo K; Dziuban E; Kiyaga C; Mbah H; Mengistu J; Mots'oane T; Mwangi C; Mwangi JW; Mwasekaga M; N'tale J; Naluguza M; Ssewanyana I; Stevens W; Zungu I; Bhairavabhotla R; Chun H; Gaffga N; Jadczak S; Lloyd S; Nguyen S; Pati R; Sleeman K; Zeh C; Zhang G; Alexander H
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):775-778. PubMed ID: 34043612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
    DeVos J; McCarthy K; Sewe V; Akinyi G; Junghae M; Opollo V; Nouhin J; Shafer R; Zeh C; Ramos A; Alexander H; Chang J
    Microbiol Spectr; 2022 Jun; 10(3):e0177621. PubMed ID: 35510849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on HIV viral load in plasma and drug resistance among AIDS patients receiving antiretroviral treatment in Dehong prefecture,Yunnan province].
    Yao S; Yang J; Zhou L; Li Y; Wang J; Gao J; Xu Y; Yang W; Li P; Shi Y; Zhang Y; Cao D; Yang M; Zhai Z; Xiang L; Yang Y; Ye R; He N; Duan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Apr; 35(4):411-6. PubMed ID: 25009031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.
    Guichet E; Aghokeng A; Serrano L; Bado G; Toure-Kane C; Eymard-Duvernay S; Villabona-Arenas CJ; Delaporte E; Ciaffi L; Peeters M
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1159-1162. PubMed ID: 27342228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghana's HIV epidemic and PEPFAR's contribution towards epidemic control.
    Ali H; Amoyaw F; Baden D; Durand L; Bronson M; Kim A; Grant-Greene Y; Imtiaz R; Swaminathan M
    Ghana Med J; 2019 Mar; 53(1):59-62. PubMed ID: 31138945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir.
    da Silva J; Pals S; Chang J; Hackett S; Godfrey C; Raizes E
    J Infect Dis; 2022 Feb; 225(3):364-366. PubMed ID: 34282844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of HIV drug resistance and public health implications in low- and middle-income countries.
    Bertagnolio S; De Luca A; Vitoria M; Essajee S; Penazzato M; Hong SY; McClure C; Duncombe C; Jordan MR
    Antivir Ther; 2012; 17(6):941-53. PubMed ID: 22898622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    Siberry GK; Amzel A; Ramos A; Rivadeneira ED
    J Infect Dis; 2017 Dec; 216(suppl_9):S838-S842. PubMed ID: 29045697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of HIV-1 Drug Escape on the Global Treatment Landscape.
    Collier DA; Monit C; Gupta RK
    Cell Host Microbe; 2019 Jul; 26(1):48-60. PubMed ID: 31295424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
    Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
    BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.
    Lecher S; Ellenberger D; Kim AA; Fonjungo PN; Agolory S; Borget MY; Broyles L; Carmona S; Chipungu G; De Cock KM; Deyde V; Downer M; Gupta S; Kaplan JE; Kiyaga C; Knight N; MacLeod W; Makumbi B; Muttai H; Mwangi C; Mwangi JW; Mwasekaga M; Ng'Ang'A LW; Pillay Y; Sarr A; Sawadogo S; Singer D; Stevens W; Toure CA; Nkengasong J
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1287-90. PubMed ID: 26605986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
    Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the US president's emergency plan for AIDS relief (PEPFAR) HIV and AIDS program on the Nigerian health system.
    Odekunle FF; Odekunle RO
    Pan Afr Med J; 2016; 25():143. PubMed ID: 28292105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.